Anju Life Sciences Software
Private Company
Total funding raised: $40M
Overview
Anju Software is a mature, revenue-generating private company that provides a comprehensive software platform for clinical trials and medical affairs operations. Its core offerings include the eClinical Suite (featuring EDC, CTMS, and AI-driven tools like Luminee) and the Medical Affairs Suite, which are designed to integrate with existing client infrastructure. With a strong client base including the majority of top global pharmaceutical firms and CROs, Anju focuses on data aggregation, analytics, and workflow optimization to reduce clinical trial timelines and enhance decision-making. The company is actively investing in AI to automate key processes and expand its market position.
Technology Platform
Integrated software platform for life sciences, featuring an eClinical Suite (EDC, CTMS, AI-driven trial build) and a Medical Affairs Suite. The platform connects and merges data from diverse sources, emphasizing configurability, scalability, and AI/ML for automation and insights.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Anju competes in a crowded market with major players like Veeva Systems (Veeva Vault Clinical, CRM), Medidata Solutions (a Dassault Systèmes company), and Oracle Health Sciences. Its differentiation lies in its integrated suite approach, specific AI capabilities like Luminee for trial building, and a long-standing focus on the life sciences niche rather than being a division of a broader tech conglomerate.